与尖蛋白相关的病理管理策略
Matthew T J Halma1, Christof Plothe2, Paul Marik3
1EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.
Microorganisms
|June 15, 2023
概括
本综述审查了长期COVID-19和COVID-19疫苗损伤的治疗方法,两者都与尖端蛋白有关. 它详细介绍了这些疾病的治疗选择,机制和证据.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 血管医学 血管医学
背景情况:
- 由于COVID-19的流行,导致了两个相关的疾病:长期COVID-19和COVID-19疫苗损伤.
- 这两种情况都与SARS-CoV-2尖端蛋白有潜在的病因联系.
- 尖蛋白可以通过各种机制引起伤害,包括血管损伤.
研究的目的:
- 对长期的COVID-19和COVID-19疫苗损伤的当前治疗选择进行审查和总结.
- 在这些条件下探索与尖蛋白相关的潜在危害机制.
- 评估现有和新兴治疗方案的证据基础.
主要方法:
- 对长期COVID-19和疫苗损伤治疗研究的系统文献综述.
- 对尖蛋白机制和血管效应的研究分析.
- 对临床试验数据和病例报告对治疗疗效的评估.
主要成果:
- 确定了几种针对尖端蛋白及其下游效应的治疗策略.
- 突出了血管功能障碍作为这两种情况的关键机制的作用.
- 评估了支持不同治疗方式的不同水平的证据.
结论:
- 长期COVID-19和疫苗损伤的有效治疗方案是非常重要的,因为它们的流行率.
- 了解各种机制,特别是血管机制,是开发向治疗的关键.
- 需要进一步的研究来加强最佳患者管理的证据基础.
相关概念视频
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
01:28Pneumonia IV: Management
399
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
399